These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10378725)

  • 1. Oral methotrexate: the hazard of different tablet strengths.
    Schott JM; Rigby SP; McNally JD; Keat A; Higgens CS
    Rheumatology (Oxford); 1999 Apr; 38(4):382. PubMed ID: 10378725
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methotrexate: advantages of subcutaneous administration].
    Krüger K
    Z Rheumatol; 2008 Jul; 67(4):332-3. PubMed ID: 18443809
    [No Abstract]   [Full Text] [Related]  

  • 3. Superficial Tissue Necrosis Related to Methotrexate Injection in a Patient With Rheumatoid Arthritis.
    Estrada Alarcon PV; García-Díaz S; Oña M; Corominas H
    J Clin Rheumatol; 2015 Oct; 21(7):370. PubMed ID: 26398466
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral methotrexate: hazard of different tablet strengths.
    Hordon LD; Le Gallez P; Isdale AH
    Rheumatology (Oxford); 1999 Dec; 38(12):1304. PubMed ID: 10587572
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R; Herborn G
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
    Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
    Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising low-dose methotrexate for rheumatoid arthritis-A review.
    Lucas CJ; Dimmitt SB; Martin JH
    Br J Clin Pharmacol; 2019 Oct; 85(10):2228-2234. PubMed ID: 31276602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What dose of folic acid to use with methotrexate in rheumatoid arthritis?
    Bramley D
    Drug Ther Bull; 2021 Jul; 59(7):103-106. PubMed ID: 34162667
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance.
    Dhir V; Aggarwal A
    J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277
    [No Abstract]   [Full Text] [Related]  

  • 11. Safe prescribing of methotrexate for rheumatoid arthritis.
    Kirkham BW
    Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus-induced pneumonia in a rheumatoid arthritis patient treated with low dose methotrexate.
    Thomas E; Olive P; Mazyad H; Blotman F
    Clin Exp Rheumatol; 1997; 15(5):583-4. PubMed ID: 9307872
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 14. [Against parenteral gold therapy in rheumatoid arthritis].
    Kellner H
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.
    Rozin A; Schapira D; Balbir-Gurman A; Braun-Moscovici Y; Markovits D; Militianu D; Nahir MA
    Ann Rheum Dis; 2002 Aug; 61(8):756-7. PubMed ID: 12117691
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety of weekly low dose oral methotrexate in an Oriental population with rheumatoid arthritis.
    Thumboo J; Koh WH; Leong KH; Boey ML; Feng PH
    Ann Acad Med Singap; 1997 Mar; 26(2):205-9. PubMed ID: 9208075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral methotrexate for the treatment of rheumatoid arthritis.
    Yazici Y; Bata Y
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Appearance of impotence in relation to the use of methotrexate].
    Riba N; Moreno F; Costa J; Olive A
    Med Clin (Barc); 1996 Apr; 106(14):558. PubMed ID: 8656751
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors.
    Mameli A; Barcellona D; Marongiu F
    Am J Ther; 2017; 24(1):e106-e107. PubMed ID: 27574942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.